Mark H. Einstein
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 17
- Uterine Myomas and Treatments 3
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 12
- Cancer Research top 10%
- Oncology top 10%
- Global Cancer Incidence and Screening 3
- Biotechnology top 10%
-
- Cervical Cancer and HPV Research 5
-
- Estrogen and related hormone effects 4
- BRCA gene mutations in cancer 2
-
- Colorectal and Anal Carcinomas 4
- Co-authors
- Gary L. GoldbergHoward D. StricklerGloria S. HuangNicole NevadunskyGurpreet KaurAlyson B. MoadelAnne Van ArsdaleJuliana Gebb
- Journals
- Gynecologic Oncology (12 papers)Journal of Clinical Oncology (4 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesCanadaRwanda
In The Last Decade
Mark H. Einstein
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Obstetrics and Gynecology 536
- Reproductive Medicine 362
- Cancer Research 209
- Oncology 357
- Biotechnology 79
Countries citing papers authored by Mark H. Einstein
This map shows the geographic impact of Mark H. Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Einstein more than expected).
Fields of papers citing papers by Mark H. Einstein
This network shows the impact of papers produced by Mark H. Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Einstein. The network helps show where Mark H. Einstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark H. Einstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2016 | 32 | |
| 4 | 2015 | 9 | |
| 5 | 2015 | 17 | |
| 6 | 2015 | 38 | |
| 7 | 2014 | 79 | |
| 8 | 2013 | 12 | |
| 9 | 2013 | 6 | |
| 10 | 2013 | 113 | |
| 11 | 2013 | 48 | |
| 12 | 2012 | 15 | |
| 13 | 2012 | 32 | |
| 14 | 2011 | 41 | |
| 15 | 2009 | 16 | |
| 16 | 2007 | 24 | |
| 17 | 2007 | 94 | |
| 18 | 2007 | 51 | |
| 19 | 2006 | 15 | |
| 20 | 2006 | 6 |
About Mark H. Einstein
Mark H. Einstein is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (12 papers), Cervical Cancer and HPV Research (5 papers), Estrogen and related hormone effects (4 papers), Colorectal and Anal Carcinomas (4 papers), Global Cancer Incidence and Screening (3 papers), Uterine Myomas and Treatments (3 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Obstetrics and Gynecology (536 citations), Reproductive Medicine (362 citations), Cancer Research (209 citations), Oncology (357 citations) and Biotechnology (79 citations). Mark H. Einstein has collaborated with scholars based in United States, Canada and Rwanda. Frequent co-authors include Gary L. Goldberg, Howard D. Strickler, Gloria S. Huang, Nicole Nevadunsky, Gurpreet Kaur, Alyson B. Moadel, Anne Van Arsdale, Juliana Gebb, Arthee Jahangir and Wilber Quispe‐Tintaya. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Investigational New Drugs, Obstetrics and Gynecology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.